Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D9FW
|
|||
| Former ID |
DIB000208
|
|||
| Drug Name |
DP-VPA
|
|||
| Synonyms |
TVA; RAP-valproate; SPD-421; Valproic acid prodrug, Shire; RAP-valproate, D-Pharm
Click to Show/Hide
|
|||
| Indication | Bipolar disorder [ICD-11: 6A60; ICD-10: F31] | Approved | [1] | |
| Company |
D-Pharm Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Gamma-aminobutyric acid receptor (GAR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008928) | |||
| REF 2 | DP-VPA D-Pharm. Curr Opin Investig Drugs. 2002 Jun;3(6):921-3. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.